Corveus Medical

Corveus Medical, originally known as Caridian Medical, is a healthcare company located in Houston, Texas. Launched in 2022, the company operates within the medical devices sub-industry, focusing on the development of catheter-based devices designed for targeted nerve ablation in the upper abdomen. These devices are specifically engineered to minimize collateral tissue damage during ablation procedures. Corveus Medical’s innovative approach also includes a catheter-based solution aimed at treating chronic heart failure. As a part of the Y Combinator W22 batch, the company is in its early stages of development and comprises a small team of three members. It serves a broad range of regions including the United States of America, America/Canada, and also offers remote services.